StatStrip Glucose Meter Update: The Result May Be Accurate—but Assigned to the Wrong Patient

What if a glucose reading is accurate, but the result ends up in the wrong patient's medical record?

That's the concern behind a Nova Biomedical StatStrip glucose meter correction—and the FDA has clarified what affected facilities should do while awaiting a software update.

What Happened?

The FDA issued a Class I recall communication on October 20, 2026, and updated its guidance on October 30.

The correction affects the StatStrip Glucose Hospital Meter Gen 2.0, models 63685 and 66739. Earlier StatStrip generations are not included.

According to Nova Biomedical, a barcode-scanning issue may cause previously displayed patient or quality-control information to remain on the meter screen.

If that information is accepted, a glucose result could be assigned to the wrong patient or quality-control record.

Importantly, Nova says the problem does not affect the analytical accuracy of the glucose measurement itself.

The concern is which patient receives the result in the record.

As of October 5, Nova reported one serious injury and no deaths associated with the issue.

What Has the FDA Clarified?

The FDA says facilities with an alternative glucose meter should stop using affected Gen 2.0 meters until the software update is available.

While awaiting that update, the manufacturer's instructions include specific safeguards for affected systems.

These include configuring available patient-validation settings when supported by the facility's electronic medical record integration, setting automatic operator logout after each test, and verifying patient identification after barcode scanning and again when results appear.

Facilities must also follow their established processes for escalating and correcting results assigned to the wrong record.

Nova anticipates a phased software rollout in November 2026, subject to completing verification and validation.

Why It Matters to Surgical Professionals

This story illustrates a problem that extends beyond glucose monitoring.

A clinically accurate measurement can still become unsafe when it is connected to the wrong patient.

Digital workflows depend on identification, data transfer, software configuration, and communication.

The same principle matters throughout perioperative care, where information moves among devices, electronic records, and clinical teams.

Technology can reduce some forms of error while introducing others that require different safeguards.

The FTLOS Takeaway

Accurate data is not enough. It must also belong to the correct patient.

This correction highlights the importance of device updates, clear communication, reliable identification processes, and coordination between clinical teams, laboratory services, information technology, and leadership.

Patient safety depends on the entire information pathway—not just the number on the screen.

Join the Conversation

What helps your team recognize when a technology problem may affect patient identification or documentation?

U.S. Food and Drug Administration. “Hospital Glucose Meter Correction: Nova Biomedical Updates Use Instructions for StatStrip Glucose Hospital Meter Systems.” FDA, updated 30 Oct. 2026, https://www.fda.gov/medical-devices/medical-device-recalls-and-early-alerts/hospital-glucose-meter-correction-nova-biomedical-updates-use-instructions-statstrip-glucose.

Nova Biomedical. “Nova Biomedical Announces Global Medical Device Correction for StatStrip Glucose Hospital Meter.” FDA, 5 Oct. 2026, https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/nova-biomedicalr-announces-global-medical-device-correction-statstripr-glucose-hospital-meter.